Skip to Main content Skip to Navigation
Journal articles

Aminoguanidine Hydrazone Derivatives as Nonpeptide NPFF1 Receptor Antagonists Reverse Opioid Induced Hyperalgesia

Abstract : Neuropeptide FF receptors (NPFF1R and NPFF2R) and their endogenous ligand neuropeptide FF have been shown previously to display antiopioid properties and to play a critical role in the adverse effects associated with chronic administrations of opiates including the development of opioid-induced hyperalgesia and analgesic tolerance. In this work, we sought to identify novel NPFF receptors ligands by focusing our interest in a series of heterocycles as rigidified nonpeptide NPFF receptor ligands, starting from already described aminoguanidine hydrazones (AGHs). Binding experiments and functional assays highlighted AGH 1n and its rigidified analogue 2-amino-dihydropyrimidine 22e for in vivo experiments. As shown earlier with the prototypical dipeptide antagonist RF9, both 1n and 22e reduced significantly the long lasting fentanyl-induced hyperalgesia in rodents. Altogether these data indicate that AGH rigidification maintains nanomolar affinities for both NPFF receptors, while improving antagonist character toward NPFF1R.
Complete list of metadatas

Cited literature [51 references]  Display  Hide  Download

https://hal-upec-upem.archives-ouvertes.fr/hal-02323065
Contributor : Martine Schmitt <>
Submitted on : Tuesday, October 22, 2019 - 1:09:25 PM
Last modification on : Wednesday, May 27, 2020 - 4:44:04 PM

Identifiers

Citation

Hassan Hammoud, Khadija Elhabazi, Isabelle Bertin, Valeŕie Utard, Emilie Laboureyras, et al.. Aminoguanidine Hydrazone Derivatives as Nonpeptide NPFF1 Receptor Antagonists Reverse Opioid Induced Hyperalgesia. ACS Chemical Neuroscience, American Chemical Society (ACS), 2018, 9 (11), pp.2599-2609. ⟨10.1021/acschemneuro.8b00099⟩. ⟨hal-02323065⟩

Share

Metrics

Record views

315